Compounds > benzenaminium, 4,4'-(3-oxo-1,5-pentanediyl)bis(n,n-dimethyl-n-2-propenyl-), dibromide
Page last updated: 2024-08-21

benzenaminium, 4,4'-(3-oxo-1,5-pentanediyl)bis(n,n-dimethyl-n-2-propenyl-), dibromide and Vascular Diseases

benzenaminium, 4,4'-(3-oxo-1,5-pentanediyl)bis(n,n-dimethyl-n-2-propenyl-), dibromide has been researched along with Vascular Diseases in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Carson, K; Geula, C; Mesulam, M; Price, B1

Other Studies

1 other study(ies) available for benzenaminium, 4,4'-(3-oxo-1,5-pentanediyl)bis(n,n-dimethyl-n-2-propenyl-), dibromide and Vascular Diseases

ArticleYear
Cholinesterases in the amyloid angiopathy of Alzheimer's disease.
    Annals of neurology, 1992, Volume: 31, Issue:5

    Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid; Benzenaminium, 4,4'-(3-oxo-1,5-pentanediyl)bis(N,N-dimethyl-N-2-propenyl-), Dibromide; Butyrylcholinesterase; Cholinesterases; Histocytochemistry; Humans; Immunohistochemistry; Microscopy, Electron; Staining and Labeling; Tetraisopropylpyrophosphamide; Vascular Diseases

1992